Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectationsBusiness live – latest updatesThe owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations. Continue reading...
Novo Nordisk’s shares fall sharply after testing of CagriSema falls short of investors’ expectations
The owner of Wegovy and Ozempic has suffered a significant setback, as its highly anticipated new weight-loss treatment was labelled “obsolete” after disappointing clinical trials.
Novo Nordisk’s shares fell sharply on Monday after the results from testing the Danish company’s CagriSema drug fell short of investors’ expectations.
Continue reading...
We are living in a collapsing property because of cost-cutting and delays over our subsidence claimLV= General Insurance...
She says a lack of fairness can make ‘people turn inwards’Healey vows to stick to fiscal rules in budget built on hopeLi...
Andy Burnham hails nationalisation of much-criticised service between London, Birmingham and GlasgowBritain’s biggest in...
Government announcement sparks a rally in FTSE-listed housebuilders, but there are still a lot of unknownsLabour’s modes...
Supermarket chain declares ‘increasing confidence’ in its growth plans after posting record annual revenue of £19bnBusin...
Chancellor sets out measures to support jobs and growth in conference speech but vows fiscal discipline in budgetAnalysi...
No other articles in this category yet.
